Kreutz R, Hübner N, Ganten D, Lindpaintner K
Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA.
Circulation. 1995 Nov 1;92(9):2381-4. doi: 10.1161/01.cir.92.9.2381.
An allelic variant of the ACE gene has been found to be linked to plasma angiotensin-converting enzyme (ACE) activity in humans and has been implicated in the etiology of some common cardiovascular disorders. Previously, we have shown significant genetic linkage of blood pressure to a region on rat chromosome 10 that contains ACE in an experimental F2-intercross between the stroke-prone spontaneously hypertensive rat (SHRSPHD) and the normotensive Wistar-Kyoto (WKYHD-0) reference strain. Subsequent investigations revealed marked differences in plasma ACE activity among the SHRSPHD and WKYHD-0 strains. Nonetheless, the physiological relevance of these findings remained obscure. We therefore investigated the genetic determination of plasma ACE activity and its relation to blood pressure and dietary NaCl exposure in a model of experimental genetic hypertension, the SHRSPHD.
We conducted a further crossbreeding experiment between SHRSPHD and a congenic reference strain, WKYHD-1, that carries a 6-centimorgan (cM) long, SHRSP-homologous segment introgressed in chromosome 10, 26 cM remote from ACE. This allowed us to contrast effects on blood pressure and ACE activity conferred by the ACE locus with other more remote loci within the congenic chromosomal region. Genetic analysis in this F2 (WKYHD-1 x SHRSPHD) cross revealed that plasma ACE activity was determined almost entirely by genetic effects of the ACE gene locus (lod score = 43). However, neither plasma ACE nor the ACE locus showed any cosegregation with blood pressure before or after dietary NaCl exposure.
These results demonstrate that a molecular variant of the ACE gene determines plasma ACE activity but exhibits no direct effect on blood pressure. Moreover, the findings also exclude the possibility that plasma ACE is secondarily affected by blood pressure or excess dietary NaCl exposure. Our results reconcile the previous discrepancy between findings in human and experimental hypertension.
已发现一种血管紧张素转换酶(ACE)基因的等位基因变体与人类血浆血管紧张素转换酶(ACE)活性相关,并与某些常见心血管疾病的病因有关。此前,我们在易中风自发性高血压大鼠(SHRSPHD)和正常血压的Wistar-Kyoto(WKYHD-0)参考品系之间的实验性F2杂交中发现,血压与大鼠10号染色体上包含ACE的区域存在显著的遗传连锁。随后的研究揭示了SHRSPHD和WKYHD-0品系之间血浆ACE活性存在显著差异。然而,这些发现的生理相关性仍然不明。因此,我们在实验性遗传高血压模型SHRSPHD中研究了血浆ACE活性的遗传决定因素及其与血压和饮食中氯化钠暴露的关系。
我们在SHRSPHD和一个同源参考品系WKYHD-1之间进行了进一步的杂交实验,WKYHD-1在10号染色体上携带一个6厘摩(cM)长的、与SHRSP同源的片段,该片段在距离ACE 26 cM处导入。这使我们能够对比ACE基因座与同源染色体区域内其他更远基因座对血压和ACE活性的影响。在这个F2(WKYHD-1×SHRSPHD)杂交中的遗传分析表明,血浆ACE活性几乎完全由ACE基因座的遗传效应决定(优势对数分数=43)。然而,在饮食中暴露于氯化钠之前或之后,血浆ACE和ACE基因座均未显示与血压有任何共分离现象。
这些结果表明,ACE基因的分子变体决定血浆ACE活性,但对血压没有直接影响。此外,这些发现还排除了血浆ACE受到血压或过量饮食中氯化钠暴露继发影响的可能性。我们的结果调和了先前人类和实验性高血压研究结果之间的差异。